SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Rocket Lab Corp. engages in the development of rocket launch and control systems for the space and defense industries. It operates through the Launch Services and Space Systems segments. The Launch Services segment provides launch services to customers on a dedicated mission or ride-share basis. The Space Systems segment consists of spacecraft engineering and design services, spacecraft components, spacecraft manufacturing, and on-orbit mission operations. The company was founded by Peter Beck in 2006 and is headquartered in Long Beach, CA.

Rocket Lab Corp.

Rocket Lab USA Inc

Rocket Lab is experiencing high volatility as investors weigh record revenue and a massive backlog against an EPS miss and concerns surrounding the Neutron rocket development schedule. The community is sharply divided, with bulls pointing to the company's strong growth and strategic expansion while skeptical traders focus on valuation concerns and the risks of further development delays.

XRP is a decentralized digital asset and the native token of the XRP Ledger, a Layer 1 blockchain designed for high-performance global payments. Its primary value proposition is offering a fast, cost-effective alternative to traditional banking systems by enabling near-instant cross-border settlements that finalize in three to five seconds. By serving as a neutral bridge asset between different fiat currencies, it helps financial institutions lower liquidity costs and eliminates the need for pre-funded accounts.  The network is unique because it utilizes a federated consensus protocol instead of energy-intensive mining or staking. This system achieves deterministic finality through a Unique Node List of trusted validators who must reach an eighty percent agreement threshold to permanently record transactions. This infrastructure supports a sustained throughput of 1,500 transactions per second and includes a built-in decentralized exchange that allows for the automated trading of any tokenized asset without intermediaries.  The project traces its origins back to 2004 with Ryan Fugger before being co-founded in its modern form by Jed McCaleb and Chris Larsen. The company, now known as Ripple, works with major financial institutions as partners and investors to build global payment solutions. To protect the network from spam, a small amount of XRP is burned during every transaction, and the token is further utilized by institutions as collateral to access traditional markets and manage digital asset infrastructure.  Institutional adoption of the asset reached a major milestone in November 2025 when the SEC approved the first wave of spot XRP ETFs. These products, offered by major issuers including Bitwise, Grayscale, 21Shares, Canary Capital, and Franklin Templeton, are now listed on prominent exchanges like the NYSE Arca, Nasdaq, and Cboe BZX. While Ripple remains a key contributor to the ecosystem, the underlying XRP Ledger continues to operate as an open-source and decentralized network.

Ripple

XRP is trending amid intense debate over the stalled Clarity Act, with community members polarized between those viewing the current price consolidation as a strategic accumulation opportunity and those concerned that the asset has lost utility momentum. Discussions are dominated by speculation regarding potential support levels near the one-dollar mark, as traders weigh regulatory uncertainty against the long-term infrastructure narrative.

Fermi, Inc. engages in the development of energy infrastructure. It intends to develop an energy and data center development campus to support the needs of to-be-built AI infrastructure. The company was founded by Rick Perry, Toby Neugebauer and Griffin Perry on January 10, 2025 and is headquartered in Amrillo, TX.

Fermi Inc

Fermi LLC

Fermi LLC is trending following a massive binding lease agreement with TensorWave that is projected to generate billions in revenue, sparking heavy community debate over its potential to become a cornerstone of the AI infrastructure sector. Investors are particularly focused on the 'global leader in AI' guarantor mentioned in the deal, with speculation fueling intense discussion regarding a potential short squeeze and the company's ability to scale its data center capacity.

Redwire Corp. engages in the development and provision of space and defense technologies and mission-critical solutions for government, commercial, and civil customers. Its offerings include spacecraft platforms, space infrastructure, avionics, sensors and payloads, power generation systems, radio frequency systems, microgravity research and manufacturing technologies, autonomous systems, optical sensors, and digital engineering solutions. The company was founded in 2020 and is headquartered in Jacksonville, FL.

Redwire Corporation

Redwire Corp

Redwire Corporation is seeing significant market momentum driven by record revenue growth and a substantial expansion in its contracted backlog. Community discussions are highly bullish, with investors actively debating the potential for a short squeeze and long-term valuation re-rating as the company gains traction in the space infrastructure and defense sectors.

Archer Aviation, Inc. engages in the development of electric vertical take-off and landing (eVTOL) aircraft. The company was founded by Brett Adcock and Adam Goldstein on October 16, 2018, and is headquartered in San Jose, CA.

Archer Aviation Inc - Ordinary Shares - Class A

Archer Aviation Inc

Archer Aviation is experiencing significant trading activity driven by a strategic agreement to acquire Boeing's Wisk Aero, Insitu, and SkyGrid subsidiaries, which expands the company's platform into autonomous flight and defense while securing Boeing as a major shareholder. Community sentiment is divided between optimism over this pivot into defense and autonomous technology and skepticism regarding potential dilution, ongoing cash burn, and the company's progress on its primary commercial eVTOL certification goals.

Hims & Hers Health, Inc. operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.

Hims & Hers Health Inc - Ordinary Shares - Class A

Hims & Hers Health Inc

Hims & Hers Health is currently in focus as investors balance strong top-line revenue growth and potential peptide expansion against market concerns regarding margin compression and recent FTC regulatory noise. The community is actively debating whether current price levels represent a strategic buying opportunity ahead of upcoming earnings, with many long-term bulls highlighting subscriber growth and management's guidance as key drivers for a potential recovery.

Babcock & Wilcox Enterprises, Inc. engages in the provision of fossil and renewable power generation and environmental equipment. It operates through the B&W segment. The company was founded by George H. Babcock, Stephen Wilcox, Jr., and Joseph P. Manton in 1856 and is headquartered in Akron, OH.

Babcock & Wilcox Enterprises Inc

Babcock & Wilcox is trending following strong quarterly results, with investors focusing on a rapidly expanding multi-billion dollar backlog driven by AI data center and power infrastructure demand. The community is actively discussing the stock's long-term growth potential and recent institutional activity, despite lingering volatility from short-selling pressure.

SPDR Gold Trust - SPDR Gold Shares

SPDR Gold Shares ETF

GLD is trending as traders analyze weakening U.S. labor data and potential shifts in interest rate expectations, fueling community debate over whether the asset is staging a breakout or forming a bull trap. Market participants remain focused on its technical performance relative to key support levels and broader geopolitical tensions, with many using the ETF as a hedge against currency uncertainty.

Moonlake Immunotherapeutics operates as a clinical-stage biotechnology company. It offers tri-specific Nanobody, Sonelokimab to address significant unmet needs in inflammatory skin and joint diseases. The company was founded by Kristian Reich, Jorge Santos da Silva, and Arnout Ploos van Amstel in 2021 and is headquartered in Zug, Switzerland.

MoonLake Immunotherapeutics - Ordinary Shares - Class A

MoonLake Immunotherapeutics

MoonLake Immunotherapeutics is facing intense community scrutiny and price volatility following mixed clinical trial results and subsequent financing filings, with shareholders actively debating whether recent shelf offerings signal necessary capital flexibility for commercialization or premature dilution. Investors remain focused on the company's long-term potential as a multi-indication franchise while heavily monitoring upcoming trial readouts and potential M&A activity for further catalysts.

Chainlink is the industry-standard decentralized oracle network that solves the "oracle problem" by connecting smart contracts with real-world data. Blockchains cannot access external information on their own, so Chainlink acts as a secure bridge, enabling smart contracts to react to real-world events using verified, tamper-proof data. It is widely considered one of the first decentralized oracle networks and is the market leader in bringing off-chain data on-chain.  The platform operates through a decentralized network of nodes that fetch, validate, and deliver data to smart contracts. When a contract requests information like a stock price, a committee of independent nodes retrieves and aggregates the data to reach consensus, then delivers a single trustworthy answer. Chainlink offers a suite of services including Data Feeds for asset prices, CCIP for cross-chain token transfers and messaging, Automation for triggering smart contract functions, and Proof of Reserve for verifying asset collateralization.  Chainlink has established itself as critical infrastructure for both DeFi and institutional adoption, with partnerships including Swift, Euroclear, Mastercard, UBS, ANZ, Fidelity International, and J.P. Morgan. Its institutional products include the Chainlink Runtime Environment for tokenized asset workflows, Confidential Compute for privacy-preserving computation, and the Automated Compliance Engine for embedding regulatory rules into smart contracts.  The LINK token is the native asset used to pay node operators for services, fund subscription accounts, and incentivize network security through staking. Node operators stake LINK as collateral, which can be slashed if they provide inaccurate data. Chainlink was co-founded in 2017 by Sergey Nazarov and Steve Ellis, who co-authored the white paper with Ari Juels, and raised $32 million in its September 2017 ICO.

ChainLink

Chainlink is trending as investors debate the impact of the stalled Clarity Act on its long-term potential, with the community split between those accumulating in anticipation of institutional adoption and skeptics frustrated by its recent price stagnation. Supporters point to its critical role as infrastructure for tokenized real-world assets and its integration with major financial players, while many traders continue to monitor key technical support levels amidst ongoing market volatility.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Gilead, Merck, Eli Lilly Lead $106B Biopharma Takeover Wave In 2026

Equity

Biopharma M&A has surged to $106 billion across 201 deals through early June 2026, putting the sector on track for its strongest full-year total since the 2019 pre-pandemic peak, CNBC reported.

Actinium Appoints Accomplished Oncology Expert Steffen Heeger MD, MSc as Chief Medical Officer to Drive Rejuvenated Pipeline Development

Actinium Appoints Accomplished Oncology Expert Steffen Heeger MD, MSc as Chief Medical Officer to Drive Rejuvenated Pipeline Development Actinium Appoints Accomplished Oncology Expert Steffen Heeger MD, MSc as Chief Medical Officer to Drive Rejuvenated Pipeline Development PR Newswire NEW YORK...

Are SEM, UNF, CNTA, ASRT Obtaining Fair Deals for their Shareholders?

Are SEM, UNF, CNTA, ASRT Obtaining Fair Deals for their Shareholders? Are SEM, UNF, CNTA, ASRT Obtaining Fair Deals for their Shareholders? PR Newswire NEW YORK, May 19, 2026 Insiders may stand to receive substantial financial benefits not available to ordinary shareholders. The proposed...

Are CNTA, WSR, GDOT Obtaining Fair Deals for their Shareholders?

Are CNTA, WSR, GDOT Obtaining Fair Deals for their Shareholders? Are CNTA, WSR, GDOT Obtaining Fair Deals for their Shareholders? PR Newswire NEW YORK, May 12, 2026 Insiders may stand to receive...

$HAREHOLDER ALERT: The M&A Class Action Firm Launches Legal Inquiry for the Merger--CLBK, NFBK, AFBI, and CNTA

$HAREHOLDER ALERT: The M&A Class Action Firm Launches Legal Inquiry for the Merger--CLBK, NFBK, AFBI, and CNTA $HAREHOLDER ALERT: The M&A Class Action Firm Launches Legal Inquiry for the Merger--CLBK, NFBK, AFBI, and CNTA PR Newswire NEW YORK, May 11, 2026 NEW YORK, May 11, 2026 /PRNewswire...

Centessa Pharmaceuticals Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Centessa Pharmaceuticals plc - CNTA

Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (KSF) are investigating the proposed sale of Centessa Pharmaceuticals plc (NasdaqGS: CNTA...

LLY Stock Jumps After Q1 Earnings Beat, 2026 Guidance Raised

LLY jumps after crushing Q1 estimates and raising 2026 outlook, powered by surging Mounjaro and Zepbound sales and strong global demand.

Centessa Pharmaceuticals (NASDAQ:CNTA) Reaches New 12-Month High  - Still a Buy?

Centessa Pharmaceuticals (NASDAQ:CNTA) Sets New 52-Week High - Still a Buy...

Centessa Pharmaceuticals PLC Sponsored ADR (NASDAQ:CNTA) Short Interest Down 47.5% in April

Centessa Pharmaceuticals PLC Sponsored ADR (NASDAQ:CNTA - Get Free Report) was the recipient of a significant drop in short interest in the month of April. As of April 15th, there was short interest totaling 3,468,688 shares, a drop of 47.5% from the March 31st total of 6,607,633 shares. Based on...

Eli Lilly’s Been On An Acquisition Spree This Year – Here’s A Look At Its Major Deals 

Eli Lilly made several multi-billion dollar acquisitions in 2026, with a strong focus on strengthening its oncology pipeline.

Centessa Pharmaceuticals Plc operates as clinical-stage pharmaceutical company, which engages in the discovery, development, and delivery of medicines that are transformational for patients. It is primarily focused on developing orexin receptor agonists for neurological and neurodegenerative disorders, including programs targeting narcolepsy, idiopathic hypersomnia, and other neuropsychiatric conditions, as well as its early-stage LockBody immuno-oncology platform. The company was founded on October 26, 2020 and is headquartered in Altrincham, the United Kingdom.

Centessa Pharmaceuticals plc - ADR

Bullish Sentiment

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Feed

News

Sentiment

Earnings

Fundamentals

Info

CNTACentessa Pharmaceuticals PLC - ADR

Fundamentals

Connect Stocktwits to ChatGPT

Latest CNTA News